{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:22:10Z","timestamp":1791303730016,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T00:00:00Z","timestamp":1373760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T00:00:00Z","timestamp":1373760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/nm.3246","type":"journal-article","created":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T20:26:48Z","timestamp":1373833608000},"page":"1030-1038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models"],"prefix":"10.1038","volume":"19","author":[{"given":"Sonia","family":"Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos M","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A","family":"Pouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Mart\u00ednez-Turrillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Torres-Peraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona K","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Luj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"P\u00e9rez-Ota\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,14]]},"reference":[{"key":"BFnm3246_CR1","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993 (1997).","journal-title":"Science"},{"key":"BFnm3246_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075\u20131081 (1995).","journal-title":"Neuron"},{"key":"BFnm3246_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","volume":"15","author":"G Schaffar","year":"2004","unstructured":"Schaffar, G. et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15, 95\u2013105 (2004).","journal-title":"Mol. Cell"},{"key":"BFnm3246_CR4","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","volume":"3","author":"LS Kaltenbach","year":"2007","unstructured":"Kaltenbach, L.S. et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82 (2007).","journal-title":"PLoS Genet."},{"key":"BFnm3246_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","volume":"15","author":"H Goehler","year":"2004","unstructured":"Goehler, H. et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol. Cell 15, 853\u2013865 (2004).","journal-title":"Mol. Cell"},{"key":"BFnm3246_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1523\/JNEUROSCI.1409-03.2004","volume":"24","author":"ZH Qin","year":"2004","unstructured":"Qin, Z.H. et al. Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J. Neurosci. 24, 269\u2013281 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","volume":"9","author":"JY Li","year":"2003","unstructured":"Li, J.Y., Plomann, M. & Brundin, P. Huntington's disease: a synaptopathy? Trends Mol. Med. 9, 414\u2013420 (2003).","journal-title":"Trends Mol. Med."},{"key":"BFnm3246_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nn1680","volume":"9","author":"I P\u00e9rez-Ota\u00f1o","year":"2006","unstructured":"P\u00e9rez-Ota\u00f1o, I. et al. Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1\/syndapin1. Nat. Neurosci. 9, 611\u2013621 (2006).","journal-title":"Nat. Neurosci."},{"key":"BFnm3246_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","volume":"58","author":"MS Levine","year":"1999","unstructured":"Levine, M.S. et al. Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knock-in mouse models of Huntington's disease. J. Neurosci. Res. 58, 515\u2013532 (1999).","journal-title":"J. Neurosci. Res."},{"key":"BFnm3246_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron, M.M. et al. Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849\u2013860 (2002).","journal-title":"Neuron"},{"key":"BFnm3246_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.1244","volume":"66","author":"C Cepeda","year":"2001","unstructured":"Cepeda, C. et al. NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66, 525\u2013539 (2001).","journal-title":"J. Neurosci. Res."},{"key":"BFnm3246_CR12","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet, G.A. et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 21, 9112\u20139123 (2001).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood, A.J. et al. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 65, 178\u2013190 (2010).","journal-title":"Neuron"},{"key":"BFnm3246_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/321168a0","volume":"321","author":"MF Beal","year":"1986","unstructured":"Beal, M.F. et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168\u2013171 (1986).","journal-title":"Nature"},{"key":"BFnm3246_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/30748","volume":"393","author":"S Das","year":"1998","unstructured":"Das, S. et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393, 377\u2013381 (1998).","journal-title":"Nature"},{"key":"BFnm3246_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuron.2009.06.016","volume":"63","author":"AC Roberts","year":"2009","unstructured":"Roberts, A.C. et al. Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron 63, 342\u2013356 (2009).","journal-title":"Neuron"},{"key":"BFnm3246_CR17","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/hmg\/11.21.2547","volume":"11","author":"J Modregger","year":"2002","unstructured":"Modregger, J., DiProspero, N.A., Charles, V., Tagle, D.A. & Plomann, M. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Hum. Mol. Genet. 11, 2547\u20132558 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3246_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nature06731","volume":"452","author":"J Lim","year":"2008","unstructured":"Lim, J. et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 452, 713\u2013718 (2008).","journal-title":"Nature"},{"key":"BFnm3246_CR19","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow, E.J. et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12, 1555\u20131567 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3246_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805\u2013810 (2004).","journal-title":"Nature"},{"key":"BFnm3246_CR21","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1523\/JNEUROSCI.0346-04.2004","volume":"24","author":"Q Li","year":"2004","unstructured":"Li, Q. et al. A syntaxin 1, G\u03b1(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J. Neurosci. 24, 4070\u20134081 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1523\/JNEUROSCI.21-04-01228.2001","volume":"21","author":"I Perez-Ota\u00f1o","year":"2001","unstructured":"Perez-Ota\u00f1o, I. et al. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J. Neurosci. 21, 1228\u20131237 (2001).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR23","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1128\/MCB.00420-09","volume":"29","author":"X Li","year":"2009","unstructured":"Li, X. et al. Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity. Mol. Cell Biol. 29, 6106\u20136116 (2009).","journal-title":"Mol. Cell Biol."},{"key":"BFnm3246_CR24","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.1102026","volume":"305","author":"M Park","year":"2004","unstructured":"Park, M., Penick, E.C., Edwards, J.G., Kauer, J.A. & Ehlers, M.D. Recycling endosomes supply AMPA receptors for LTP. Science 305, 1972\u20131975 (2004).","journal-title":"Science"},{"key":"BFnm3246_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cne.10314","volume":"450","author":"HK Wong","year":"2002","unstructured":"Wong, H.K. et al. Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J. Comp. Neurol. 450, 303\u2013317 (2002).","journal-title":"J. Comp. Neurol."},{"key":"BFnm3246_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.01.004","volume":"91","author":"MA Henson","year":"2010","unstructured":"Henson, M.A., Roberts, A.C., Perez-Ota\u00f1o, I. & Philpot, B.D. Influence of the NR3A subunit on NMDA receptor functions. Prog. Neurobiol. 91, 23\u201337 (2010).","journal-title":"Prog. Neurobiol."},{"key":"BFnm3246_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"BFnm3246_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1091\/mbc.10.2.501","volume":"10","author":"B Qualmann","year":"1999","unstructured":"Qualmann, B., Roos, J., DiGregorio, P.J. & Kelly, R.B. Syndapin I, a synaptic dynamin-binding protein that associates with the neural Wiskott-Aldrich syndrome protein. Mol. Biol. Cell 10, 501\u2013513 (1999).","journal-title":"Mol. Biol. Cell"},{"key":"BFnm3246_CR29","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals, J.M. et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 24, 7727\u20137739 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR30","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1523\/JNEUROSCI.4320-04.2005","volume":"25","author":"NK Mazarakis","year":"2005","unstructured":"Mazarakis, N.K. et al. Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J. Neurosci. 25, 3059\u20133066 (2005).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","volume":"26","author":"JM Van Raamsdonk","year":"2007","unstructured":"Van Raamsdonk, J.M. et al. Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol. Dis. 26, 189\u2013200 (2007).","journal-title":"Neurobiol. Dis."},{"key":"BFnm3246_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","volume":"21","author":"RK Graham","year":"2006","unstructured":"Graham, R.K. et al. Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol. Dis. 21, 444\u2013455 (2006).","journal-title":"Neurobiol. Dis."},{"key":"BFnm3246_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","volume":"11","author":"VC Wheeler","year":"2002","unstructured":"Wheeler, V.C. et al. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum. Mol. Genet. 11, 633\u2013640 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3246_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nbd.2012.07.001","volume":"48","author":"R Mart\u00ednez-Turrillas","year":"2012","unstructured":"Mart\u00ednez-Turrillas, R. et al. The NMDA receptor subunit GluN3A protects against 3-nitroproprionic\u2013induced striatal lesions via inhibition of calpain activation. Neurobiol. Dis. 48, 290\u2013298 (2012).","journal-title":"Neurobiol. Dis."},{"key":"BFnm3246_CR35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland, G.A., Williams, R.S. & DiFiglia, M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770\u2013773 (1985).","journal-title":"Science"},{"key":"BFnm3246_CR36","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1042\/AN20100007","volume":"2","author":"DM Cummings","year":"2010","unstructured":"Cummings, D.M., Cepeda, C. & Levine, M.S. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease. ASN Neuro 2, e00036 (2010).","journal-title":"ASN Neuro"},{"key":"BFnm3246_CR37","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk, J.M. et al. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 25, 4169\u20134180 (2005).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR38","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb, J.A. et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc. Natl. Acad. Sci. USA 97, 6809\u20136814 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3246_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel, J.P. Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol. 115, 55\u201369 (2008).","journal-title":"Acta Neuropathol."},{"key":"BFnm3246_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/NEN.0b013e31816b4aee","volume":"67","author":"DD Rudnicki","year":"2008","unstructured":"Rudnicki, D.D., Pletnikova, O., Vonsattel, J.P., Ross, C.A. & Margolis, R.L. A comparison of huntington disease and huntington disease\u2013like 2 neuropathology. J. Neuropathol. Exp. Neurol. 67, 366\u2013374 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnm3246_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nbd.2011.03.017","volume":"43","author":"PH Reinhart","year":"2011","unstructured":"Reinhart, P.H. et al. Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay. Neurobiol. Dis. 43, 248\u2013256 (2011).","journal-title":"Neurobiol. Dis."},{"key":"BFnm3246_CR42","doi-asserted-by":"publisher","first-page":"11402","DOI":"10.1073\/pnas.0503634102","volume":"102","author":"EJ Slow","year":"2005","unstructured":"Slow, E.J. et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc. Natl. Acad. Sci. USA 102, 11402\u201311407 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3246_CR43","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto, S. et al. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med. 15, 1407\u20131413 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3246_CR44","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1073\/pnas.0511256103","volume":"103","author":"RA Bodner","year":"2006","unstructured":"Bodner, R.A. et al. Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc. Natl. Acad. Sci. USA 103, 4246\u20134251 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3246_CR45","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1152\/jn.00308.2004","volume":"92","author":"L Li","year":"2004","unstructured":"Li, L., Murphy, T.H., Hayden, M.R. & Raymond, L.A. Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor\u2013mediated synaptic currents in a mouse model of Huntington disease. J. Neurophysiol. 92, 2738\u20132746 (2004).","journal-title":"J. Neurophysiol."},{"key":"BFnm3246_CR46","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy, K.P. et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci. 20, 5115\u20135123 (2000).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","volume":"8","author":"MT Usdin","year":"1999","unstructured":"Usdin, M.T., Shelbourne, P.F., Myers, R.M. & Madison, D.V. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8, 839\u2013846 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3246_CR48","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch, G. et al. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci. 27, 4424\u20134434 (2007).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jnr.20651","volume":"82","author":"AJ Starling","year":"2005","unstructured":"Starling, A.J. et al. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington's disease. J. Neurosci. Res. 82, 377\u2013386 (2005).","journal-title":"J. Neurosci. Res."},{"key":"BFnm3246_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham, G.E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682\u2013696 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm3246_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","volume":"81","author":"C Cepeda","year":"2007","unstructured":"Cepeda, C., Wu, N., Andre, V.M., Cummings, D.M. & Levine, M.S. The corticostriatal pathway in Huntington's disease. Prog. Neurobiol. 81, 253\u2013271 (2007).","journal-title":"Prog. Neurobiol."},{"key":"BFnm3246_CR52","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1523\/JNEUROSCI.1067-09.2009","volume":"29","author":"N Nakanishi","year":"2009","unstructured":"Nakanishi, N. et al. Neuroprotection by the NR3A subunit of the NMDA receptor. J. Neurosci. 29, 5260\u20135265 (2009).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR53","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","volume":"96","author":"O Hansson","year":"1999","unstructured":"Hansson, O. et al. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid\u2013induced striatal excitotoxicity. Proc. Natl. Acad. Sci. USA 96, 8727\u20138732 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3246_CR54","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","volume":"29","author":"RK Graham","year":"2009","unstructured":"Graham, R.K. et al. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease. J. Neurosci. 29, 2193\u20132204 (2009).","journal-title":"J. Neurosci."},{"key":"BFnm3246_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1242\/jcs.01611","volume":"118","author":"S Irwin","year":"2005","unstructured":"Irwin, S. et al. RNA association and nucleocytoplasmic shuttling by ataxin-1. J. Cell Sci. 118, 233\u2013242 (2005).","journal-title":"J. Cell Sci."},{"key":"BFnm3246_CR56","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","volume":"15","author":"A Lloret","year":"2006","unstructured":"Lloret, A. et al. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. Hum. Mol. Genet. 15, 2015\u20132024 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3246_CR57","doi-asserted-by":"publisher","first-page":"Pl8","DOI":"10.1126\/stke.2002.137.pl8","volume":"2002","author":"DR Grosshans","year":"2002","unstructured":"Grosshans, D.R., Clayton, D.A., Coultrap, S.J. & Browning, M.D. Analysis of glutamate receptor surface expression in acute hippocampal slices. Sci. STKE 2002, Pl8 (2002).","journal-title":"Sci. STKE"},{"key":"BFnm3246_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1326-6-71","volume":"6","author":"A Giralt","year":"2011","unstructured":"Giralt, A., Carreton, O., Lao-Peregrin, C., Martin, E.D. & Alberch, J. Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol. Neurodegener. 6, 71 (2011).","journal-title":"Mol. Neurodegener."},{"key":"BFnm3246_CR59","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/hipo.20883","volume":"22","author":"A Ricobaraza","year":"2012","unstructured":"Ricobaraza, A., Cuadrado-Tejedor, M., Marco, S., Perez-Otano, I. & Garcia-Osta, A. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22, 1040\u20131050 (2012).","journal-title":"Hippocampus"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.3246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.3246","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.3246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T18:07:31Z","timestamp":1650046051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,14]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFnm3246"],"URL":"https:\/\/doi.org\/10.1038\/nm.3246","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,14]]},"assertion":[{"value":"6 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}